老年房颤患者在开始抗凝预防血栓栓塞时出血：每况愈下。 - Suppr | 超能文献

Bleeding while starting anticoagulation for thromboembolism prophylaxis in elderly patients with atrial fibrillation: from bad to worse.

作者信息

Wyse D George

出版信息

Circulation. 2007 May 29;115(21):2684-6. doi: 10.1161/CIRCULATIONAHA.107.704122.

DOI:10.1161/CIRCULATIONAHA.107.704122

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Bleeding while starting anticoagulation for thromboembolism prophylaxis in elderly patients with atrial fibrillation: from bad to worse.老年房颤患者在开始抗凝预防血栓栓塞时出血：每况愈下。

Circulation. 2007 May 29;115(21):2684-6. doi: 10.1161/CIRCULATIONAHA.107.704122.

2

[Anticoagulation in atrial fibrillation].[心房颤动的抗凝治疗]

Herz. 2008 Feb;33(1):13-9. doi: 10.1007/s00059-008-3090-8.

3

Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation.90岁以上患者接受维生素K拮抗剂治疗非瓣膜性心房颤动的出血率。

Blood Coagul Fibrinolysis. 2009 Jan;20(1):47-51. doi: 10.1097/MBC.0b013e32831be9da.

4

Stroke prevention versus bleeding risk of vitamin-K antagonists: a double-edged sword in patients with atrial fibrillation who require surgery.华法林抗凝相关卒中预防与出血风险：需要手术的房颤患者的一把双刃剑。

Cardiovasc Ther. 2009 Winter;27(4):223-5. doi: 10.1111/j.1755-5922.2009.00110.x.

5

Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation.老年患者接受维生素K拮抗剂治疗非瓣膜性心房颤动时的出血率

Blood Coagul Fibrinolysis. 2009 Jul;20(5):392-3. doi: 10.1097/MBC.0b013e32832aec47.

6

[Oral anticoagulants. Large study finds minor risk of hemorrhage in the elderly].

MMW Fortschr Med. 2011 Sep 15;153(37):16.

7

Clinical practice. Care of patients receiving long-term anticoagulant therapy.临床实践。接受长期抗凝治疗患者的护理。

N Engl J Med. 2003 Aug 14;349(7):675-83. doi: 10.1056/NEJMcp025373.

8

Anticoagulation in atrial fibrillation: a contemporary viewpoint.心房颤动的抗凝治疗：当代观点

Heart Rhythm. 2007 Mar;4(3 Suppl):S34-9. doi: 10.1016/j.hrthm.2006.12.001. Epub 2006 Dec 6.

9

Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.反对观点：“华法林应是老年房颤患者血栓预防的首选药物”。关于老年房颤患者使用口服抗凝治疗的注意事项。

Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343.

10

[It's a balancing act being on the safe side].保持安全是一种平衡行为。

Anasthesiol Intensivmed Notfallmed Schmerzther. 2014 Mar;49(3):172-3. doi: 10.1055/s-0034-1372231. Epub 2014 Apr 7.

引用本文的文献

1

Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary care.未进行自我监测的口服抗凝剂患者的安全相关知识：基层医疗中的一项基线调查。

BMC Fam Pract. 2014 May 25;15:104. doi: 10.1186/1471-2296-15-104.

2

Practice nursed-based, individual and video-assisted patient education in oral anticoagulation--protocol of a cluster-randomized controlled trial.基于实践的、个体化的和视频辅助的口服抗凝患者教育--一项整群随机对照试验方案。

BMC Fam Pract. 2011 Apr 10;12:17. doi: 10.1186/1471-2296-12-17.